Qorvo Gets FDA Emergency Use Authorization (EUA) For SARS-CoV-2 Antigen Test
The U.S. Food and Drug Administration (FDA) has granted emergency use authorization (EUA) for Qorvo’s (NASDAQ: QRVO) Qorvo Omnia SARS-CoV-2 Antigen Test in Point-of-Care (POC) settings.
